Search results
Results from the WOW.Com Content Network
Let's consider two income-focused corporations whose shares are worth holding on to well beyond next year: AbbVie (NYSE: ABBV) and Abbott Laboratories (NYSE: ABT). 2 Top Dividend Stocks to Buy and ...
If you want to see more stocks in this selection, check out 5 Best Pharma Dividend Stocks To Buy. As per a Bloomberg report dated September 12, the global bio-pharma market was valued at $274.10 ...
AbbVie is one of the more attractive dividend-paying stocks in the pharmaceutical industry, with a 3.6% yield at recent prices. It's also one of its industry's fastest dividend raisers.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The stock's 6.7% dividend yield is the highest it's ever been outside of the financial crisis in 2008-2009. A high yield can signal trouble, but Pfizer is doing just fine.
On Dec. 12, Pfizer's board of directors approved an increase in the quarterly cash dividend to $0.43 per share, marking its 345th consecutive quarterly payment.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Last December, Pfizer raised its dividend payout to 0.42 per share, which works out to a yield of 6.4% at recent prices. Investors who buy now can look forward to a 16th consecutive annual-payout ...